Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse

From the Departments of Medicine (R.S.C., E.A.K., R.C.L.B., A.C.) and Pathobiology (M.E.R.), University of Washington, Seattle.

Abstract—Oxidized low density lipoprotein (LDL) promotes atherogenesis. Although pharmacological antioxidants such as probucol inhibit both LDL oxidation and atherosclerosis in hyperlipidemic animals, the effects of natural antioxidants such as vitamin E are inconclusive. To further determine the effects of supplemental dietary antioxidants in vivo, we evaluated whether combined dietary antioxidants (0.1% vitamin E, 0.5% ß-carotene, and 0.05% vitamin C) inhibit LDL oxidation and fatty streak lesion development in homozygous LDL receptor–null (LDLR^-/-) mice fed a high-fat, high-cholesterol diet. An additional group of mice were fed black tea, which has been shown to inhibit LDL oxidation in vitro. After receiving a high-fat, high-cholesterol diet for 8 weeks, the combined antioxidant–supplemented (antioxidant) group (n=18), tea group (n=19), and control group (n=17) had equivalent plasma cholesterol levels. LDL oxidation, as measured by the lag phase of conjugated diene formation, was markedly inhibited in the antioxidant group compared with the tea or control groups [mean lag phases=143±7 (antioxidant), 100±5 (tea), and 84±4 (control) minutes; P<0.0001 antioxidant versus tea or control]. The cross-sectional surface area of fatty streak lesions in the aortic sinus was reduced by 60% in the antioxidant group compared with both the tea and control groups (P<0.0001 antioxidant versus tea or control). There was no difference in lesion area between tea and control groups. Although both LDL oxidation and atherosclerosis were significantly inhibited in the antioxidant group, no correlation between lag phase values and lesion size was observed among individual animals. Furthermore, black tea did not inhibit fatty streak development in LDLR^-/- mice. These data suggest that combined natural dietary antioxidants inhibit both LDL oxidation and atherogenesis in animals with elevated LDL but that inhibition of LDL oxidation alone may not prevent the development of atherosclerosis.

Key Words: atherosclerosis • antioxidants • LDL • black tea

This article has been cited by other articles:

				L. R. Tannock, E. A. Kirk, V. L. King, R. LeBoeuf, T. N. Wight, and A. Chait Glucosamine Supplementation Accelerates Early but Not Late Atherosclerosis in LDL Receptor-Deficient Mice J. Nutr., November 1, 2006; 136(11): 2856 - 2861. [Abstract] [Full Text] [PDF]

				X. Yi and N. Maeda {alpha}-Lipoic Acid Prevents the Increase in Atherosclerosis Induced by Diabetes in Apolipoprotein E-Deficient Mice Fed High-Fat/Low-Cholesterol Diet. Diabetes, August 1, 2006; 55(8): 2238 - 2244. [Abstract] [Full Text] [PDF]

				P. Sharma, N. Herrmann, P. A. Rochon, M. Lee, R. Croxford, L. Rothenburg, S. E. Black, and K. L. Lanctot Perceptions of Natural Health Products Among Patients Attending a Memory Clinic American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 156 - 163. [Abstract] [PDF]

				C. S. Carlson, P. J. Heagerty, T. S. Hatsukami, R. J. Richter, J. Ranchalis, J. Lewis, T. J. Bacus, L. A. McKinstry, G. D. Schellenberg, M. Rieder, et al. TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease J. Lipid Res., May 1, 2006; 47(5): 1014 - 1024. [Abstract] [Full Text] [PDF]

				M. L. Blackhall, R. G. Fassett, J. E. Sharman, D. P. Geraghty, and J. S. Coombes Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1970 - 1975. [Abstract] [Full Text] [PDF]

				K. E. Lewis, E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice Circulation, August 3, 2004; 110(5): 540 - 545. [Abstract] [Full Text] [PDF]

				C. Napoli, S. Williams-Ignarro, F. de Nigris, L. O. Lerman, L. Rossi, C. Guarino, G. Mansueto, F. Di Tuoro, O. Pignalosa, G. De Rosa, et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice PNAS, June 8, 2004; 101(23): 8797 - 8802. [Abstract] [Full Text] [PDF]

				K.-Y. Chyu, S. M. Babbidge, X. Zhao, R. Dandillaya, A. G. Rietveld, J. Yano, P. Dimayuga, B. Cercek, and P. K. Shah Differential Effects of Green Tea-Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E-Null Mice Circulation, May 25, 2004; 109(20): 2448 - 2453. [Abstract] [Full Text] [PDF]

				B. Frei and J. V. Higdon Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies J. Nutr., October 1, 2003; 133(10): 3275S - 3284. [Abstract] [Full Text] [PDF]

				S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al. Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention J. Am. Coll. Nutr., February 1, 2003; 22(1): 18 - 35. [Abstract] [Full Text] [PDF]

				G. P. Jarvik, N. T. Tsai, L. A. McKinstry, R. Wani, V. H. Brophy, R. J. Richter, G. D. Schellenberg, P. J. Heagerty, T. S. Hatsukami, and C. E. Furlong Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1329 - 1333. [Abstract] [Full Text] [PDF]

				D. Steinberg and J. L. Witztum Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis? Circulation, April 30, 2002; 105(17): 2107 - 2111. [Full Text] [PDF]

				A. A. Qureshi, W. A. Salser, R. Parmar, and E. E. Emeson Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice J. Nutr., October 1, 2001; 131(10): 2606 - 2618. [Abstract] [Full Text] [PDF]

				M. Haidari, E. Javadi, M. Kadkhodaee, and A. Sanati Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease Clin. Chem., July 1, 2001; 47(7): 1234 - 1240. [Abstract] [Full Text] [PDF]

				Y.-Y. Fan, K. S. Ramos, and R. S. Chapkin Dietary {{gamma}}-Linolenic Acid Suppresses Aortic Smooth Muscle Cell Proliferation and Modifies Atherosclerotic Lesions in Apolipoprotein E Knockout Mice J. Nutr., June 1, 2001; 131(6): 1675 - 1681. [Abstract] [Full Text]

				A. R. Collins, W. P. Meehan, U. Kintscher, S. Jackson, S. Wakino, G. Noh, W. Palinski, W. A. Hsueh, and R. E. Law Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 365 - 371. [Abstract] [Full Text] [PDF]

				N. Ishizaka, Y. Ishizaka, E. Takahashi, M. Yamakado, and H. Hashimoto High Serum Bilirubin Level Is Inversely Associated With the Presence of Carotid Plaque Stroke, February 1, 2001; 32 (2): 580 - 583. [Full Text] [PDF]

				Y. Miura, T. Chiba, I. Tomita, H. Koizumi, S. Miura, K. Umegaki, Y. Hara, and M. Ikeda Tea Catechins Prevent the Development of Atherosclerosis in Apoprotein E-Deficient Mice J. Nutr., January 1, 2001; 131(1): 27 - 32. [Abstract] [Full Text]

				R. Asmis and J. Jelk Vitamin E Supplementation of Human Macrophages Prevents Neither Foam Cell Formation Nor Increased Susceptibility of Foam Cells to Lysis by Oxidized LDL Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2078 - 2086. [Abstract] [Full Text] [PDF]

				F. Visioli, L. Borsani, and C. Galli Diet and prevention of coronary heart disease: the potential role of phytochemicals Cardiovasc Res, August 18, 2000; 47(3): 419 - 425. [Abstract] [Full Text] [PDF]

				F. Eitner, Y. Cui, G. Grouard-Vogel, K. L. Hudkins, A. Schmidt, T. Birkebak, M. B. Agy, S.-L. Hu, W. R. Morton, D. M. Anderson, et al. Rapid Shift from Virally Infected Cells to Germinal Center-Retained Virus after HIV-2 Infection of Macaques Am. J. Pathol., April 1, 2000; 156(4): 1197 - 1207. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott Biologically Active Oxidized Phospholipids J. Biol. Chem., September 3, 1999; 274(36): 25189 - 25192. [Full Text] [PDF]